Mahindra Manulife Flexi Cap Fund
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity and equity-related securities across market capitalization.
Growthvine rating: 3/5 — ranked #28 of 56 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹14.61 (as of 2026-10-23) |
|---|
| AUM | ₹1,510 Cr |
|---|
| Expense ratio | 1.81% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Kirti Dalvi |
|---|
| Exit load | 1% for redemption within 3 months |
|---|
Performance & risk
| 5-year annualised return | 8.30% |
|---|
| Sharpe ratio | 0.19 |
|---|
| Standard deviation | 14.74% |
|---|
| Max drawdown | −17.96% |
|---|
| Alpha | -1.64 |
|---|
| Beta | 0.93 |
|---|
Over 5 years, captured 95.1% of Nifty 500's upside and 95.4% of its downside.
Market cap allocation
| Large cap | 53.0% |
|---|
| Mid cap | 22.5% |
|---|
| Small cap | 24.5% |
|---|
Concentration
| Top 5 holdings | 17.9% |
|---|
| Top 10 holdings | 28.0% |
|---|
| Total holdings | 72 |
|---|
| Index overlap | 38.1% |
|---|
| Active share | 61.9% |
|---|
Top holdings
- ICICI Bank Ltd. — 6.4%
- HDFC Bank Ltd. — 3.9%
- AXIS Bank Ltd. — 2.5%
- Eternal Limited — 2.5%
- Bharti Airtel Ltd. — 2.5%
- Bajaj Finance Limited — 2.4%
- Triparty Repo — 2.3%
- Larsen & Toubro Limited — 2.0%
- Kotak Mahindra Bank Ltd. — 1.9%
- Federal Bank Ltd. — 1.9%
Top sectors
- Banking & Financial — 23.4%
- Pharma & Biotech — 9.7%
- Industrial Products — 7.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −12.0% | Q4 (Bottom) | #46 of 50 |
| 2025 | 6.8% | Q2 | #13 of 43 |
| 2024 | 14.6% | Q4 (Bottom) | #34 of 42 |
| 2023 | 30.9% | Q2 | #11 of 36 |
| 2022 | 1.4% | Q2 | #11 of 30 |